Juan Carlos de la Fuente Mancera

ORCID: 0000-0001-9770-4626
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Infective Endocarditis Diagnosis and Management
  • Cardiac Valve Diseases and Treatments
  • Cardiovascular Function and Risk Factors
  • Ultrasound in Clinical Applications
  • Music History and Culture
  • Phonocardiography and Auscultation Techniques
  • Cardiovascular Health and Risk Factors
  • Heart Failure Treatment and Management
  • Cardiomyopathy and Myosin Studies
  • RNA and protein synthesis mechanisms
  • Genetic Neurodegenerative Diseases
  • Ear and Head Tumors
  • Scientific Research and Technology
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Structural Anomalies and Repair
  • Cardiac Health and Mental Health
  • Transplantation: Methods and Outcomes
  • Neurogenetic and Muscular Disorders Research
  • Reconstructive Facial Surgery Techniques
  • Viral Infections and Immunology Research

Instituto Nacional de Cardiología
2019-2024

Hospital Clínic de Barcelona
2022-2024

Universitat de Barcelona
2021-2023

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
2021

Background Little is known about the impact of transcatheter mitral valve edge-to-edge repair on changes in left ventricular ejection fraction (LVEF) and effect an acute reduction LVEF prognosis. We aimed to assess after for both primary secondary regurgitation (PMR SMR, respectively), identify rates predictors reduction, estimate its Methods Results In this international multicenter registry, patients with PMR SMR undergoing were included. assessed (LVEFR), defined as relative decrease >15%...

10.1161/jaha.123.029735 article EN cc-by-nc-nd Journal of the American Heart Association 2023-06-23

Transcatheter tricuspid valve repair (TTVr) has emerged as an alternative for the treatment of severe regurgitation (TR). We report our initial experience with edge-to-edge TTVr system in a high-volume institution. Methods: included consecutive patients who underwent systems. The primary efficacy endpoint was reduction TR at least one grade. safety procedure-related clinical serious adverse events. Results: A total 28 All presented high impact on quality life (82% NYHA class ≥ III). Triclip...

10.3390/jcm10184252 article EN Journal of Clinical Medicine 2021-09-19

10.1016/j.rec.2022.10.016 article EN Revista Española de Cardiología (English Edition) 2023-01-06

Introduction Decompensated heart failure (DHF) is the main cause of cardiovascular hospitalization. During 1-year follow-up (FU), at least one rehospitalization occurred in 56.6% patients with HF. In Mexico, HF places great burden on patients, caregivers, and healthcare systems. New strategies are essential for early diagnosis treatment DHF. Hypothesis: Use a digital tool effective remote monitoring CHF to reduce number hospitalizations and/or unscheduled visits ER. Methods: A mixed model...

10.1161/circ.146.suppl_1.13145 article EN Circulation 2022-11-08
Coming Soon ...